| Organism name | Crataegus pinnatifida |
|---|---|
| Genus | Crataegus |
| Family | Rosaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Crataegus pinnatifida |
|---|---|
| Linked NCBI taxonomy ID | 510735 |
| Linked level | species |
| Family in NCBI taxonomy | Rosaceae |
|---|---|
| ID | 3745 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00005401
|
Quercetin 3-robinoside
/ Quercetin 3-O-robinoside / Quercetin 3-O-robinobioside / Quercetin 3-O-rhamnosyl-(1->6)-galactoside |
CHEMBL32579
CHEMBL310754 CHEMBL182108 CHEMBL226335 CHEMBL502782 CHEMBL1436093 CHEMBL1532989 |
25 / 18 / 16 | No. 1 | No. 15 |
|
||
|
C00005356
|
Sexangularetin 3-glucoside
|
No. 2 | No. 15 |
|
||||
|
C00006369
|
Vitexin 2''-acetate
|
No. 22 | No. 15 |
|
||||
|
C00014090
|
Psilosin
/ Vitexin 6''-O-acetate |
No. 22 | No. 15 |
|
||||
|
C00014089
|
Vitexin 3''-O-acetate
|
No. 22 | No. 15 |
|
||||
|
C00014093
|
8-C-beta-D-Glucofuranosylapigenin 2''-O-acetate
|
No. 22 | No. 15 |
|
||||
|
C00013613
|
Pinnatifinoside A
/ (2R,3S,4S,5R)-4,5-Dihydro-3,4,5'-trihydroxy-5-(hydroxymethyl)-2'-(4-hydroxyphenyl)-spiro[furan-2(3H),8'(9'H)-[4H]furo[2,3-h][1]benzopyran]-4'-one |
No. 2945 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P33527 | Multidrug resistance-associated protein 1 | drugs | C00005401 | 0 / 0 |
| P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00005401 | 0 / 3 |
| P06746 | DNA polymerase beta | Enzyme | C00005401 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00005401 | 1 / 1 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00005401 | 1 / 1 |
| P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00005401 | 0 / 0 |
| Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00005401 | 1 / 0 |
| P11388 | DNA topoisomerase 2-alpha | Isomerase | C00005401 | 0 / 0 |
| P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00005401 | 0 / 0 |
| P27487 | Dipeptidyl peptidase 4 | S9B | C00005401 | 0 / 1 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00005401 | 0 / 0 |
| P14679 | Tyrosinase | Oxidoreductase | C00005401 | 4 / 2 |
| P06276 | Cholinesterase | Hydrolase | C00005401 | 0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00005401 | 0 / 0 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00005401 | 3 / 3 |
| Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00005401 | 2 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00005401 | 1 / 1 |
| P22303 | Acetylcholinesterase | Hydrolase | C00005401 | 1 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00005401 | 0 / 1 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00005401 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00005401 | 4 / 3 |
| P48147 | Prolyl endopeptidase | S9A | C00005401 | 0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00005401 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00005401 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00005401 | 0 / 0 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
| #203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
| #606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
| #614490 | Blood group, junior system; jr |
Q9UNQ0
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
| #278300 | Xanthinuria, type i |
P47989
|
| #112100 | Yt blood group antigen |
P22303
|
| KEGG | name | UniProt |
|---|---|---|
| H00026 | Endometrial Cancer |
P03372
(marker)
|
| H00036 | Osteosarcoma |
P08684
(marker)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
| H00038 | Malignant melanoma |
P14679
(marker)
|
| H00032 | Thyroid cancer |
P27487
(marker)
|
| H00017 | Esophageal cancer |
P35354
(related)
|
| H00025 | Penile cancer |
P35354
(related)
|
| H00046 | Cholangiocarcinoma |
P35354
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|